Article

Drug Target Identification in Triple Negative Breast Cancer Stem Cell Pathways: a computational study of gene regulatory pathways using Boolean networks

2023-05-04

Abstract excerpt

<h4>ABSTRACT</h4> Triple-negative breast cancer (TNBC) is an aggressive form of breast cancer associated with an early age of onset, greater propensity towards metastasis, and poorer clinical outcomes. It accounts for 10% to 20% of newly diagnosed breast cancer cases and disproportionately affects individuals from the African American race. While TNBC is sensitive to chemotherapy, it is also prone to relapse. Thi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: c1b10a1b-a7e5-5186-8856-3ca469582621
DOI: 10.1101/2023.05.03.539160

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Drug Target Identification in Triple Negative Breast Cancer Stem Cell Pathways: a computational study of gene regulatory pathways using Boolean networksDOI 10.1101/2023.05.03.539160Read

Drug Target Identification in Triple Negative Breast Cancer Stem Cell Pathways: A Computational Study of Gene Regulatory Pathways Using Boolean NetworksSemantic proximity Read

Gene expression profile analysis to discover molecular signatures for early diagnosis and therapies of triple-negative breast cancerSemantic proximity Read

OPTIMIZING THERAPEUTIC TARGETS FOR BREAST CANCER USING BOOLEAN NETWORK MODELSSemantic proximity Read

Molecular pathways and therapeutic targets linked to triple-negative breast cancer (TNBC).Semantic proximity Read

Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies.Semantic proximity Read

Translational drugs targeting cancer stem cells in triple-negative breast cancerSemantic proximity Read

Signaling pathways essential for triple-negative breast cancer stem-like cellsSemantic proximity Read

Identification of potential key genes and pathways predicting pathogenesis and prognosis for triple-negative breast cancerSemantic proximity Read

Identification of Therapeutic Gene Targets in Triple-Negative Breast Cancer: A Hybrid Approach Integrating Semidefinite Programming, Boolean Simulation, and Druggability AnalysisSemantic proximity Read

Triple Negative Breast Cancer: A Multi-Omics Network Discovery Strategy for Candidate Targets and Driving PathwaysSemantic proximity Read

Transcriptomic analysis revealed potential regulatory biomarkers and repurposable drugs for breast cancer treatmentSemantic proximity Read

Molecular Biology Mechanisms and Emerging Therapeutics of Triple-Negative Breast CancerSemantic proximity Read